| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |